Natalie Sacks's Insider Trades & SAST Disclosures
Natalie Sacks's most recent trade in Caribou Biosciences Inc was a trade of 40,500 Option to purchase Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Natalie Sacks.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Zymeworks BC Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Natalie Sacks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 155,000 | 155,000 | - | - | Employee Stock Option (right to buy) | |
| Caribou Biosciences Inc | Natalie Sacks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 27,500 | 27,500 | - | - | Option to purchase Common Stock | |
| Harpoon Therapeutics Inc | Natalie Sacks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 155,000 | 155,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Natalie Sacks | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges